United States

Sumitomo Dainippon Pharma Co Ltd (4506.T)

4506.T on Tokyo Stock Exchange

26 Sep 2016
Change (% chg)

-- (--)
Prev Close
Day's High
Day's Low
Avg. Vol
52-wk High
52-wk Low


Chart for 4506.T


Sumitomo Dainippon Pharma Co., Ltd., formerly Dainippon Sumitomo Pharma Co.,Ltd., is a pharmaceutical company. The Japan division manufactures and sells ethical and general use drugs. The North America division manufactures, develops, purchases and sells ethical drugs through its consolidated subsidiaries. The China division... (more)


Beta: 0.73
Market Cap(Mil.): ¥748,848.12
Shares Outstanding(Mil.): 397.90
Dividend: 9.00
Yield (%): 0.96


  4506.T Industry Sector
P/E (TTM): 27.57 36.61 36.60
EPS (TTM): 68.27 -- --
ROI: 5.08 14.46 13.91
ROE: 6.14 15.26 14.82

BRIEF-Sumitomo Dainippon readying new type of cancer treatment for release in fiscal 2017 - Nikkei

* Sumitomo Dainippon Pharma is readying new type of cancer treatment that targets culprit behind metastasis,recurrence for release in fiscal 2017-Nikkei

1:37pm EDT

Sunovion Pharma to buy Canada's Cynapsus for $624 mln

Aug 31 Sunovion Pharmaceuticals Inc, a unit of Japan's Dainippon Sumitomo Pharma Co Ltd, said it would buy Canada's Cynapsus Therapeutics Inc for about $624 million.

Aug 31 2016

BRIEF-Sumitomo Dainippon Pharma to offer early-retirement program

* Says it to offer an early-retirement program to employees, who are above 45 years old as of Nov. 30 and worked more than five years (except part of employees)

Aug 30 2016

Earnings vs. Estimates

Analyst Research Reports

Report Title Price
Provider : Thomson Reuters Stock Report
Provider : Reuters Investment Profile
Provider : MarketLine
Provider : Wright Reports
Provider : GlobalData

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.